Director Dealing

The Company announces that Dr Jim Millen, Chief Executive Officer of Physiomics, has been notified that a brokerage account with Reyker Securities plc (“Reyker”) in which he held an interest of 244,641 ordinary shares of 0.4p each in the Company (“Ordinary Shares”), has been closed and transferred to a brokerage account with James Brearley & Sons Limited, for no consideration (the “Transfer”).

Click here to read in full.